SHSE:688393 (China)
Â
Class A
Â¥
17.17
+0.33 (+1.96%)
Jul 29
Business Description
Guangzhou LBP Medicine Science & Technology Co Ltd
ISIN : CNE1000043R4
Share Class Description:
SHSE:688393: Class ATotal Employee Number:
768Compare
Compare
Traded in other countries / regions
688393.China Index Membership
SSE Composite Index IPO Date
2020-08-20Description
Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 110.1 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.9 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11.9 | |||||
3-Year Book Growth Rate | -1.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.36 | |||||
9-Day RSI | 41 | |||||
14-Day RSI | 39.57 | |||||
3-1 Month Momentum % | -24.83 | |||||
6-1 Month Momentum % | -36.7 | |||||
12-1 Month Momentum % | -43.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 9.43 | |||||
Quick Ratio | 7.85 | |||||
Cash Ratio | 4.83 | |||||
Days Inventory | 268 | |||||
Days Sales Outstanding | 194.7 | |||||
Days Payable | 92.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.59 | |||||
3-Year Dividend Growth Rate | -28.2 | |||||
Forward Dividend Yield % | 0.59 | |||||
5-Year Yield-on-Cost % | 0.57 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.8 | |||||
Operating Margin % | -11.57 | |||||
Net Margin % | -10.75 | |||||
EBITDA Margin % | -12.37 | |||||
FCF Margin % | -1.77 | |||||
OCF Margin % | 4.93 | |||||
ROE % | -3.11 | |||||
ROA % | -2.9 | |||||
ROIC % | -3.63 | |||||
3-Year ROIIC % | 86.26 | |||||
ROC (Joel Greenblatt) % | -7.17 | |||||
ROCE % | -3.53 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 30.67 | |||||
Shiller PE Ratio | 27.69 | |||||
PS Ratio | 4.55 | |||||
PB Ratio | 1.36 | |||||
Price-to-Tangible-Book | 1.45 | |||||
Price-to-Operating-Cash-Flow | 79.87 | |||||
EV-to-EBIT | -29.67 | |||||
EV-to-EBITDA | -29.67 | |||||
EV-to-Revenue | 3.67 | |||||
EV-to-FCF | -207.31 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 2.27 | |||||
| Price-to-Net-Current-Asset-Value | 3.16 | |||||
| Price-to-Net-Cash | 7.24 | |||||
Earnings Yield (Greenblatt) % | -3.37 | |||||
FCF Yield % | -0.39 | |||||
Forward Rate of Return (Yacktman) % | -47.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangzhou LBP Medicine Science & Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 351.454 | ||
| EPS (TTM) (Â¥) | -0.4 | ||
| Beta | 1.1653 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | 34.41 | ||
| 14-Day RSI | 39.57 | ||
| 14-Day ATR (Â¥) | 1.006023 | ||
| 20-Day SMA (Â¥) | 17.76 | ||
| 12-1 Month Momentum % | -43.95 | ||
| 52-Week Range (Â¥) | 15.7 - 38.96 | ||
| Shares Outstanding (Mil) | 93.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangzhou LBP Medicine Science & Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangzhou LBP Medicine Science & Technology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.100000 Cash Dividend | 2026-06-03 | 21.26 (-3.14%) | ||
| CNY 0.100000 Cash Dividend | 2025-05-29 | 27.40 (-1.37%) |
Show
Entries
Guangzhou LBP Medicine Science & Technology Co Ltd Frequently Asked Questions
What is Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393)'s stock price today?
The current price of SHSE:688393 is ¥17.17. The 52 week high of SHSE:688393 is ¥38.96 and 52 week low is ¥15.70.
When is next earnings date of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393)?
The next earnings date of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) is .
Does Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) pay dividends? If so, how much?
The Dividend Yield %  of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) is 0.59% (As of Today), Highest Dividend Payout Ratio of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) was 1. The lowest was 0.38. And the median was 0.52. The  Forward Dividend Yield % of Guangzhou LBP Medicine Science & Technology Co Ltd(SHSE:688393) is 0.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Guangzhou LBP Medicine Science & Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers